Dx dialogues: using molecular profiling to identify mutations in R/R AML

Naval Daver, MD, explains how high-resolution genomic profiling can help us identify actionable mutations in R/R AML.

Identifying gene mutations is an important step in diagnosing AML and determining the best approach to treatment.

An overview of the therapies used when acute myeloid leukemia (AML) doesn’t respond to treatment or comes back after treatment.

Mutations to the FLT3 gene are common in AML. Here’s what these mutations mean for prognosis and treatment.

While much of your cancer risk is out of your hands, you may be able to lower your odds by managing your weight.

An overview of hospice care, including the benefits it can offer and basic strategies for finding hospice care.